Shockwave Medical Inc (SWAV)
330.00
+1.01
(+0.31%)
USD |
NASDAQ |
Apr 26, 16:00
329.74
-0.26
(-0.08%)
After-Hours: 07:56
Shockwave Medical Gross Profit Margin (Quarterly): 87.53% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 87.53% |
September 30, 2023 | 86.82% |
June 30, 2023 | 86.41% |
March 31, 2023 | 86.92% |
December 31, 2022 | 87.85% |
September 30, 2022 | 86.39% |
June 30, 2022 | 86.14% |
March 31, 2022 | 86.23% |
December 31, 2021 | 84.96% |
September 30, 2021 | 83.20% |
June 30, 2021 | 82.23% |
March 31, 2021 | 75.26% |
Date | Value |
---|---|
December 31, 2020 | 71.51% |
September 30, 2020 | 73.06% |
June 30, 2020 | 65.08% |
March 31, 2020 | 62.82% |
December 31, 2019 | 61.20% |
September 30, 2019 | 61.17% |
June 30, 2019 | 58.72% |
March 31, 2019 | 57.74% |
December 31, 2018 | 34.73% |
September 30, 2018 | 45.19% |
June 30, 2018 | 48.27% |
March 31, 2018 | 39.94% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
58.72%
Minimum
Jun 2019
87.85%
Maximum
Dec 2022
77.55%
Average
83.20%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
Boston Scientific Corp | 68.65% |
AtriCure Inc | 74.91% |
Masimo Corp | 47.86% |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | 60.97% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 24.80% |
Return on Assets | 14.01% |
Return on Invested Capital | 16.06% |
Profit Margin (Quarterly) | 21.83% |
Operating Margin (Quarterly) | 21.32% |
Return on Net Operating Assets | 41.62% |